BRPI1000802B8 - processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e micropartículas matriciais de copaífera langsdorffii - Google Patents
processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e micropartículas matriciais de copaífera langsdorffiiInfo
- Publication number
- BRPI1000802B8 BRPI1000802B8 BRPI1000802A BRPI1000802A BRPI1000802B8 BR PI1000802 B8 BRPI1000802 B8 BR PI1000802B8 BR PI1000802 A BRPI1000802 A BR PI1000802A BR PI1000802 A BRPI1000802 A BR PI1000802A BR PI1000802 B8 BRPI1000802 B8 BR PI1000802B8
- Authority
- BR
- Brazil
- Prior art keywords
- matrix microparticles
- microparticles
- aerial parts
- copaiferous
- langsdorffii
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title abstract 7
- 239000011159 matrix material Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- 241000349999 Copaifera Species 0.000 abstract 3
- 208000000913 Kidney Calculi Diseases 0.000 abstract 3
- 206010029148 Nephrolithiasis Diseases 0.000 abstract 3
- -1 anti-inflammatory Substances 0.000 abstract 3
- 230000000202 analgesic effect Effects 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 230000002421 anti-septic effect Effects 0.000 abstract 2
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 abstract 2
- 239000002934 diuretic Substances 0.000 abstract 2
- 230000001882 diuretic effect Effects 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 238000002955 isolation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000006558 Dental Calculus Diseases 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 206010038478 Renal lithiasis Diseases 0.000 abstract 1
- 230000003187 abdominal effect Effects 0.000 abstract 1
- 230000002690 anti-lithiasic effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 208000013465 muscle pain Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
processo de obtenção de micropartículas matriciais de copaífera langsdoffíi (partes aéreas) e isolamento dos princípios ativos; micropartículas e compostos assim obtidos, com atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, suas formulações, produtos e usos. refere-se o presente invento a um processo de obtenção de micropartículas matriciais de copaifera iangsdorffii (partes aéreas) e do isolamento dos compostos ativos e/ou marcadores das partes aéreas da referida planta, bem como as atividades biológicas encontradas para tais micropartículas matriciais e dos compostos isolados, quais sejam: atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, bem como a utilização destes nos tratamentos de litíase renal (cálculo renal), artrites, tártaros, dores musculares e espasmódicas em geral (cólicas abdominais, renais, etc.). refere-se também as demais doenças relacionadas às atividades previamente citadas, além das formulações que podem ser originadas com as micropartículas matriciais de copaifera iangsdorffii; e/ou seus compostos isolados, como medicamentos, produtos de higiene pessoal, cosméticos, alimentos, produtos veterinários e odontológicos, etc.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1000802A BRPI1000802B8 (pt) | 2010-03-30 | 2010-03-30 | processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e micropartículas matriciais de copaífera langsdorffii |
| PCT/BR2011/000090 WO2011120118A1 (pt) | 2010-03-30 | 2011-03-29 | Processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e isolamento dos princípios ativos; micropartículas e compostos assim obtidos, com atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, suas formulações, produtos e usos. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1000802A BRPI1000802B8 (pt) | 2010-03-30 | 2010-03-30 | processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e micropartículas matriciais de copaífera langsdorffii |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1000802A2 BRPI1000802A2 (pt) | 2011-11-22 |
| BRPI1000802B1 BRPI1000802B1 (pt) | 2020-12-29 |
| BRPI1000802B8 true BRPI1000802B8 (pt) | 2021-09-08 |
Family
ID=44711247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1000802A BRPI1000802B8 (pt) | 2010-03-30 | 2010-03-30 | processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e micropartículas matriciais de copaífera langsdorffii |
Country Status (2)
| Country | Link |
|---|---|
| BR (1) | BRPI1000802B8 (pt) |
| WO (1) | WO2011120118A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112672750A (zh) * | 2018-07-10 | 2021-04-16 | 雷索尔西克斯有限公司 | 用于灭活革兰氏阳性菌和细菌孢子的组合物及其制备和使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753017B2 (en) * | 2001-11-07 | 2004-06-22 | Jrs Pharma Lp | Process for preparing dry extracts |
| BRPI0401631A (pt) * | 2004-04-22 | 2005-12-06 | Aurita Rodrigues Fl Brunharoto | Processo de obtenção e utilização de extratos, frações e substâncias isoladas de espécies de copaìfera no tratamento da litìase urinária em seres humanos e em animais |
-
2010
- 2010-03-30 BR BRPI1000802A patent/BRPI1000802B8/pt active IP Right Grant
-
2011
- 2011-03-29 WO PCT/BR2011/000090 patent/WO2011120118A1/pt not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI1000802B1 (pt) | 2020-12-29 |
| WO2011120118A1 (pt) | 2011-10-06 |
| BRPI1000802A2 (pt) | 2011-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014009851A2 (pt) | moduladores de receptor de nmda e usos dos mesmos | |
| MX2010004613A (es) | Composicion topica. | |
| BR112012016575A2 (pt) | composição para cuidado da pele/dermatológica, fator de crescimento heterólogo produzido por planta, e, método para fabricar um produto tópico | |
| BR112014031730A2 (pt) | entidades químicas, composições farmacêuticas, compostos ou sais farmaceuticamente aceitáveis dos mesmos, usos de entidades químicas ou composições e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática de pde1 e para modular a atividade da enzima pde1 | |
| EA201101424A1 (ru) | Антимикробные композиции и способы их применения | |
| BRPI1010861A8 (pt) | métodos para tratamento de dor, inflamação ou osteoartrite, pacote e formulação farmacêutica | |
| BRPI0720500A8 (pt) | Preparação líquida transdérmica | |
| BR112015005339A8 (pt) | uso de óleo de semente de fruta milagrosa como um ingrediente ativo | |
| BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
| EA201270615A1 (ru) | Противогрибковый препарат, содержащий грибковый организм | |
| AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
| FI20095606A7 (fi) | Järjestelmä ja menetelmä alhaisen suspendoituneen kiintoainepitoisuuden omaavan liuoksen tuottamiseksi ja sellaisen liuoksen käyttö | |
| EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
| BR112015012057A2 (pt) | misturas binárias fungicidas | |
| BRPI1000802B8 (pt) | processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e micropartículas matriciais de copaífera langsdorffii | |
| Vaishnav et al. | Unlocking the medicinal treasure of cinnamomum tamala (bay leaf): A comprehensive review of its therapeutic and pharmaceutical potential | |
| ES2387109B1 (es) | Pulverización farmacéutica | |
| MX2016007973A (es) | Composicion topica que comprende ingredientes naturales para el alivio de moretones o hematomas en la piel y uso de la misma. | |
| Jahan et al. | Antioxidant activity of gemmo therapeutically treated indiginous medicinal plants | |
| Avanti et al. | Plantago major synthesized silver nanoparticles in an anti-acne facial sheet mask: physical stability, safety, and efficacy | |
| CN101658538A (zh) | 一种烫伤药 | |
| Hashemi et al. | Successful treatment of common warts (Verruca vulgaris) with application of fig tree latex | |
| GB2436524A (en) | Topical composition comprising an extract of the butterbur plant | |
| Johnston | Muscle and joint pain: topical anti-inflammatories and analgesics: therapeutic | |
| BR112014032850A2 (pt) | combinações de princípios ativos, preparações cosméticas ou dermatológicas, e, uso de combinações de princípios ativos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2608 DE 29/12/2020 QUANTO AO ENDERECO. |